Such changes can affect host metabolism, contributing to an increased risk of obesity by affecting energy balance, insulin sensitivity, and systemic inflammation, as a result of modulating the expression of FXR, TGR5, and other signalling pathways [101,103,264]. The gene discussed is INS; the disease is Obesity.